Fig. 3From: SLFN5 promotes reversible epithelial and mesenchymal transformation in ovarian cancerFrequent upregulation of SLFN5 in human epithelial ovarian cancer. A-B Expression of SLFN5 in cancerous and normal ovarian tissues detected by WB. C. Expression of SLFN5 in cancerous and normal ovarian tissues analyzed by RT-PCR. D SLFN5 upregulation is significantly associated with shorter overall survival in epithelial ovarian cancer patients. E No significant correlation is observed between SLFN5 expression and progression-free survivalBack to article page